Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $1.21 Million - $1.38 Million
17,500 New
17,500 $1.32 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $1.33 Million - $1.6 Million
30,400 New
30,400 $1.52 Million
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $936,800 - $1.17 Million
-20,000 Reduced 57.14%
15,000 $799,000
Q2 2022

Aug 15, 2022

BUY
$34.86 - $63.77 $1.22 Million - $2.23 Million
35,000 New
35,000 $1.59 Million
Q1 2022

May 13, 2022

SELL
$44.33 - $57.82 $1.11 Million - $1.45 Million
-25,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$40.27 - $56.99 $2.26 Million - $3.19 Million
-56,000 Reduced 69.14%
25,000 $1.11 Million
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $3.84 Million - $6.82 Million
81,000 New
81,000 $3.9 Million
Q4 2020

Feb 16, 2021

SELL
$48.9 - $75.26 $1.22 Million - $1.88 Million
-25,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$37.23 - $50.97 $930,749 - $1.27 Million
25,000 New
25,000 $1.24 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.